These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 38171406)

  • 1. Advances and prospects of mRNA vaccines in cancer immunotherapy.
    Liu Y; Yan Q; Zeng Z; Fan C; Xiong W
    Biochim Biophys Acta Rev Cancer; 2024 Mar; 1879(2):189068. PubMed ID: 38171406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. mRNA vaccine for cancer immunotherapy.
    Miao L; Zhang Y; Huang L
    Mol Cancer; 2021 Feb; 20(1):41. PubMed ID: 33632261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The viral approach to breast cancer immunotherapy.
    Arab A; Behravan N; Razazn A; Barati N; Mosaffa F; Nicastro J; Slavcev R; Behravan J
    J Cell Physiol; 2019 Feb; 234(2):1257-1267. PubMed ID: 30146692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccinia virus-mediated cancer immunotherapy: cancer vaccines and oncolytics.
    Guo ZS; Lu B; Guo Z; Giehl E; Feist M; Dai E; Liu W; Storkus WJ; He Y; Liu Z; Bartlett DL
    J Immunother Cancer; 2019 Jan; 7(1):6. PubMed ID: 30626434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Rapid Development and Early Success of Covid 19 Vaccines Have Raised Hopes for Accelerating the Cancer Treatment Mechanism.
    Amanpour S
    Arch Razi Inst; 2021 Mar; 76(1):1-6. PubMed ID: 33818952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunotherapy as a New Therapeutic Approach for Brain and Spinal Cord Tumors.
    Medikonda R; Pant A; Lim M
    Adv Exp Med Biol; 2023; 1394():73-84. PubMed ID: 36587382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. mRNA Vaccines: The Dawn of a New Era of Cancer Immunotherapy.
    Deng Z; Tian Y; Song J; An G; Yang P
    Front Immunol; 2022; 13():887125. PubMed ID: 35720301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design of Personalized Neoantigen RNA Vaccines Against Cancer Based on Next-Generation Sequencing Data.
    Alburquerque-González B; López-Abellán MD; Luengo-Gil G; Montoro-García S; Conesa-Zamora P
    Methods Mol Biol; 2022; 2547():165-185. PubMed ID: 36068464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. mRNA vaccine development and applications: A special focus on tumors (Review).
    Chen B; Yang Y; Wang X; Yang W; Lu Y; Wang D; Zhuo E; Tang Y; Su J; Tang G; Shao S; Gu K
    Int J Oncol; 2024 Aug; 65(2):. PubMed ID: 38994758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Highlights into historical and current immune interventions for cancer.
    Cole K; Al-Kadhimi Z; Talmadge JE
    Int Immunopharmacol; 2023 Apr; 117():109882. PubMed ID: 36848790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. mRNA vaccines for cancer immunotherapy.
    Vishweshwaraiah YL; Dokholyan NV
    Front Immunol; 2022; 13():1029069. PubMed ID: 36591226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combining Tumor Vaccination and Oncolytic Viral Approaches with Checkpoint Inhibitors: Rationale, Pre-Clinical Experience, and Current Clinical Trials in Malignant Melanoma.
    Cavalcante L; Chowdhary A; Sosman JA; Chandra S
    Am J Clin Dermatol; 2018 Oct; 19(5):657-670. PubMed ID: 29961183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. mRNA Cancer Vaccines: Construction and Boosting Strategies.
    Liu X; Huang P; Yang R; Deng H
    ACS Nano; 2023 Oct; 17(20):19550-19580. PubMed ID: 37819640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical advances and ongoing trials on mRNA vaccines for cancer treatment.
    Lorentzen CL; Haanen JB; Met Ö; Svane IM
    Lancet Oncol; 2022 Oct; 23(10):e450-e458. PubMed ID: 36174631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Preventive vaccines and immunotherapy clinical trials against cervical cancer].
    Valdespino-Gómez VM
    Cir Cir; 2005; 73(1):57-69. PubMed ID: 15888272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanomedicine for advanced cancer immunotherapy.
    Diep YN; Kim TJ; Cho H; Lee LP
    J Control Release; 2022 Nov; 351():1017-1037. PubMed ID: 36220487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glioblastoma Immunotherapy: A Systematic Review of the Present Strategies and Prospects for Advancements.
    Agosti E; Zeppieri M; De Maria L; Tedeschi C; Fontanella MM; Panciani PP; Ius T
    Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37894718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current research into novel therapeutic vaccines against cervical cancer.
    Cordeiro MN; De Lima RCP; Paolini F; Melo ARDS; Campos APF; Venuti A; De Freitas AC
    Expert Rev Anticancer Ther; 2018 Apr; 18(4):365-376. PubMed ID: 29475377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunotherapy of glioblastoma: Recent advances and future prospects.
    Yuan B; Wang G; Tang X; Tong A; Zhou L
    Hum Vaccin Immunother; 2022 Nov; 18(5):2055417. PubMed ID: 35344682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic DNA Vaccines against HPV-Related Malignancies: Promising Leads from Clinical Trials.
    Tang J; Li M; Zhao C; Shen D; Liu L; Zhang X; Wei L
    Viruses; 2022 Jan; 14(2):. PubMed ID: 35215833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.